PK/PD, Biomarkers & Genomics in Clinical Trials: Strategy, Assays, Data Pipelines, and Compliance
PK/PD, Biomarkers & Genomics in Clinical Trials: Strategy, Assays, Data Pipelines, and Compliance Building a Compliant PK/PD, Biomarker, and Genomics Framework for Clinical Programs Strategy first: how PK/PD, biomarkers, and genomics shape decision-making Pharmacokinetic and pharmacodynamic work gives teams a quantitative language for dose selection, benefit–risk assessment, and labeling. At the core are PK/PD modeling…